Published: December 2022

Content warning: Graphic description, in his own words, of the injuries he sustained.

Travis Vaughan shares the story of the night of December 18, 2019, when he arrived by air ambulance to The Ottawa Hospital Trauma Centre after a snowmobile crash in rural Ottawa that left him with life-threatening injuries. This is Travis’ story, told in his own words, about how our orthopaedic trauma team was ready to save his life. 

It was a late afternoon on a Wednesday in December, and we just received our first real snowfall of the season. I was excited to get home from work to take the snowmobile out. My wife would be home from work soon, so I wasn’t planning on staying out long — just a quick loop and back home for the night. There was still light in the sky, but we were inching closer to the shortest day of the year.

I was on my way back — about 300 yards from the house — when the snowmobile hit a patch of very rough ground under the snow. As soon as the skis hit the frozen furrows of ground, the front end of the snowmobile broke apart. The machine rolled, taking me with it.

It all happened in the blink of an eye. While in the air, I remember being confused as to why the snowmobile suddenly upset, then I hit the ground hard.

“I’m grateful that through all of this, I was able to stay calm and keep my breathing steady, thanks to the reassuring support coming from the other end of the phone.”

– Travis Vaughan

Initially I didn’t think I was any worse for wear, until I looked down. My leg was torn wide open, and my femur was completely exposed — there was a lot of blood, but no pain. My adrenaline kicked in immediately. Luckily, I had stuffed my cellphone in my pocket and was able to dial 911. I explained to the calm voice of the operator that I was lying alone in a field just north of Almonte. She asked several questions, and I conveyed the severity of the situation, explaining my left leg was dangling and nearly detached. I was trying to make a tourniquet, but didn’t have a belt and wasn’t able to get my waist band torn out of my snow pants. I was acutely aware the situation was dire — if help didn’t arrive quickly, things would likely not end well. I remember her telling me there was all kinds of help on the way, and the Ornge air ambulance had been dispatched.

My hands started to numb from the bitter cold, and I wanted to call my wife, but the operator insisted I stay on the line until help arrived. I’m grateful that through all of this, I was able to stay calm and keep my breathing steady, thanks to the reassuring support coming from the other end of the phone.

Desperate for help to arrive

Unfortunately, the cold air caused my phone to die, cutting me off from the 911 operator. Sitting alone I remember thinking — you’re 32-years-old, this isn’t how it’s supposed to end. It was a surreal feeling. Strangely, it wasn’t scary — a warm calm sort of settled over my body. I remember thinking either I was going to hear sirens and see help coming, or I wasn’t, and this would be it. I started to think about my wife and family, and all the happy milestones I would miss.

But my next thought was different — and it hit me like a train — if I didn’t survive this, it would be my wife and family left to pick up the pieces, not me. I was furious with myself for succumbing to self pity while not thinking of how devastating and difficult this would be for my loved ones. This was the most intense thought I’ve ever experienced. From that moment on, I was going to give everything I had left to live; putting one hand in front of the other, I began to crawl. The next thing I knew, our dog came running towards me across the field. He looked at me with a what-did-you-do expression. He knew I was in trouble and stayed by my side as I slowly dragged myself home.

My wife, Jenn, and my brother, Tyler, who was living with us at the time, were both at home by the time I got to the house. I pushed open the door, and my wife turned and looked at me. I can still see the shock on her face. She came running towards me, grabbed me a belt and covered me with a blanket, before going to find my brother for help.  

“From that moment on, I was going to give everything I had left to live, putting one hand in front of the other, I began to crawl.”

– Travis Vaughan
Travis' dog heard his cries for help and remained by his side as Travis dragged himself home.

Tyler raced to make a tourniquet to help ease the blood loss; not many people could have done that, and I’m here because of it. Soon, the emergency responders started to arrive and they applied a proper tourniquet, started fluids, and worked to stabilize me. I was loaded into the ambulance — time was of the essence, so they quickly transported me to the awaiting air ambulance. The pilot had tried to land in the yard, however, due to trees and uneven ground, he had to set the helicopter down on the road. My memory starts to get a little fuzzy here, I’m so grateful to my wife, brother, the police officers, paramedics, and firefighters for the role they played in saving my life. 

“When I say a team, it’s no exaggeration — my family told me there were close to 20 professionals ready and waiting. It was powerful to witness, and it’s not lost on me that because I was at a Level 1 Trauma Centre, I had immediate access to any equipment necessary. This level of care is unbelievable.”

– Travis Vaughan

Unbelievable care awaited me at the Trauma Centre

When we landed at The Ottawa Hospital’s Civic Campus a full team awaited me. When I say a team, it’s no exaggeration — my family told me there were close to 20 professionals ready and waiting. It was powerful to witness, and it’s not lost on me that because I was at a Level 1 Trauma Centre, I had immediate access to any equipment necessary. This level of care is unbelievable. 

Travis with his wife, daughter, and brother.

The team had received details of my injury while I was in the air. I remember feeling the first sigh of relief when we arrived — I was in good hands. My family was also in good hands, and that was equally comforting to hear afterwards. My wife received a phone call from a physician on the way to the hospital explaining what had already been done and what was planned. When my mother, sister, and wife arrived at the hospital, they were met by a social worker who was exceptional and again briefed them on all that was going on.

“It was my wife and brother that gave me my first fighting chance to live. Now, it was up to the trauma team to do the rest.”

– Travis Vaughan

It still amazes me to this day that I remember so much about that experience. I recall the faces of the trauma team as they did a full evaluation to determine if there were any other injuries. Each person acted quickly and concisely to get answers. I remember a CT scan showed I didn’t have any head trauma and my neck was fine — but I was hypothermic because of the extent of time I was outside.

The damage to my femur and surrounding tissue was extensive and critical. I recall someone saying the tourniquet Tyler put on my leg is likely the reason I made it to the hospital alive — it was my wife and brother that gave me my first fighting chance to live. Now, it was up to the trauma team to do the rest.

What is trauma care like at The Ottawa Hospital today?
The Ottawa Hospital and its Trauma Centre at the Civic Campus are responsible for 1.3 million residents, ranging from as far west as Pembroke to as far east as Hawkesbury.
What is trauma care like at The Ottawa Hospital today?
We’re the only Level 1 Trauma Centre for adults in eastern Ontario.
What is trauma care like at The Ottawa Hospital today?
The Civic Emergency Department was renovated in 2003 to treat 60,000 patients a year, today treats over 90,000 a year, and we project that by 2030, we will need to treat more than 120,000 a year.
Previous
Next
TOH_Clipboard_Colour

In 2021–2022, we admitted 992 patients for trauma care, up from 958 in 2020–2021.

TOH_Patient in Bed_Colour

40.3% of trauma patients in 2021–2022 were 65 or older.

TOH_Icons_HazardWarning

Falls and motor vehicle collisions are the leading causes of injury at 43% and 33.8% respectively in 2021–2022.

TOH_Icon_Helicopter_Colour

67% of patients arrive directly from the scene, 33% from another facility.

TOH Icon_Radiology_Colour

Fracture cases annually: 3000+ (2000+ of these cases require hospitalization)

Orthopaedic trauma team gave me a chance at a full recovery

Getting the femur positioned back in my leg was going to be the first, and very painful, thing to do. Dr. Allan Liew, Director of Orthopaedic Trauma, was the lead, and I remember an orthopaedic resident was with me — standing right by my head. They explained how they had to try and put my femur back in my leg. The resident had a good sense of humour, which really helped in that moment, and he said to me, “Ok, this is going to suck.”

And it really did, but it had to be done to help put me on the right path to recovery. Later that night, once I was stabilized, Dr. Liew took me into surgery. I had a debridement — which is basically a thorough cleaning of the wound — and that’s when they realized there was some bone loss from the accident. What I mean by that is a piece of my femur was missing — still back in the field. So, my leg had to be stabilized with pins and bars just above the knee.

This whole surgery was crucial to reduce the risk of infection, and Dr. Liew did an incredible job with what he had to work with. That first surgery was critical in setting me up for a successful recovery.

I returned to the operating room on December 21 for another debridement, which gave my surgeons the chance to reassess how the tissues were doing, as well as the bone. Then four days later, on Christmas Eve, I had a third surgery — a definitive fix, as it was called. A plate and screws were used to stabilize my femur, but also, the surgical team needed to start the process to build back the missing bone. A block of bone cement was placed in the area where the bone was missing. Amazingly, the body will start to form a healing membrane around the cement, and six to eight weeks later I would return to have the block removed and a bone graft placed inside the membrane.

Travis underwent several critical surgeries to set him up for a successful recovery.

Orthopaedic trauma team gave me a chance at a full recovery

Getting the femur positioned back in my leg was going to be the first, and very painful, thing to do. Dr. Allan Liew, Director of Orthopaedic Trauma, was the lead, and I remember an orthopaedic resident was with me — standing right by my head. They explained how they had to try and put my femur back in my leg. The resident had a good sense of humour, which really helped in that moment, and he said to me, “Ok, this is going to suck.”

Travis underwent several critical surgeries to set him up for a successful recovery.

And it really did, but it had to be done to help put me on the right path to recovery. Later that night, once I was stabilized, Dr. Liew took me into surgery. I had a debridement — which is basically a thorough cleaning of the wound — and that’s when they realized there was some bone loss from the accident. What I mean by that is a piece of my femur was missing — still back in the field. So, my leg had to be stabilized with pins and bars just above the knee.

This whole surgery was crucial to reduce the risk of infection, and Dr. Liew did an incredible job with what he had to work with. That first surgery was critical in setting me up for a successful recovery.

I returned to the operating room on December 21 for another debridement, which gave my surgeons the chance to reassess how the tissues were doing, as well as the bone. Then four days later, on Christmas Eve, I had a third surgery — a definitive fix, as it was called. A plate and screws were used to stabilize my femur, but also, the surgical team needed to start the process to build back the missing bone. A block of bone cement was placed in the area where the bone was missing. Amazingly, the body will start to form a healing membrane around the cement, and six to eight weeks later I would return to have the block removed and a bone graft placed inside the membrane.

Finally, after 10 days in hospital, I was able to go home. While I missed Christmas with my family, they were always present at the hospital. Staff also went the extra mile to celebrate Christmas with me. I was lucky to be alive and hopeful The Ottawa Hospital’s specialist were setting me up for a full recovery. But my journey wasn’t over — one more big surgery awaited me.

‘Superman’ surgeon leaves a lasting impression

That’s when I would meet Dr. Geoff Wilkin — or as I refer to him, Superman. He’s an orthopaedic surgeon who would lead that final surgery. Initially, the plan was for a short, routine surgery for bone grafting. However, after reviewing the imaging he wasn’t pleased with how my leg was healing and decided he wanted to re-align the femur — a redo if you will. Admittedly, I was shocked by this news. I had mentally prepared for a brief procedure, and now I was in for a six-hour surgery. But the truth was, I was having difficulty bending my knee, and Dr. Wilkin explained this was the best opportunity to get it right. If this wasn’t fixed properly, I would face a lifetime of issues that would impact my quality of life.

“Dr. Wilkin’s thoroughness and determination gave me the best chance at a future with a fully functional leg. He went so far past the extra mile to give me the best opportunity at recovery. He's given me a second lease on life — I will be forever grateful for that.”

– Travis Vaughan

On February 13, 2020 — just before COVID-19 hit our city — I was back in the operating room. Mine was a complex case. First, Dr. Wilkin had to remove that cement spacer in my femur. Then, he realigned the femur into a better position and attached two new plates to it. Up next was the bone grafting, where bone was harvested from my pelvis and placed in my thigh.

Dr. Wilkin’s thoroughness and determination gave me the best chance at a future with a fully functional leg. He went so far past the extra mile to give me the best opportunity at recovery. He’s given me a second lease on life — I will be forever grateful for that.

Travis with his orthopaedic surgeon, Dr. Geoff Wilkin.
Travis with his daughter.

On to the best part. Thanks to the team that was waiting for me the night of the accident and those I would meet in the days and weeks ahead, including a long list of amazing nurses, I’m doing well. I don’t know that I’ll be skiing in the Rockies or running a marathon, but I was around to experience something far better. In October 2021, my wife and I welcomed our first child, a daughter. I now can chase her around the playground and enjoy any other activities she chooses to pursue growing up.

I’m beyond lucky to live in a city with access to the world-class care I received that cold December night. While my life hung in the balance, the trauma team was ready for me, and that’s something I will never forget.

Dr. Geoff Wilkin

“There are two important time points in acute orthopaedic trauma care. There's the initial time of injury, when we are focused on stabilizing measures to save life and limb. But the second, and bigger, piece of my job is putting people’s injuries back together as perfectly as possible to maximize their recovery and their return to function. My goal is to get people back to the level of activity they had before their injury — that's what we are always striving for with any injured patient.

Travis was one of those guys that every time I saw him, he was doing better and better. Despite everything he went through, his positive attitude and determination to get better never failed. Today, he's doing really well — he is enjoying an active life with his young family and his injury is largely a thing of the past. It feels great to have helped him get there.”
Download episode #72 of Pulse Podcast to hear Travis Vaughan reunited with his orthopaedic surgeon, Dr. Geoff Wilkin.

Listen Now:

Published: January 2023

In late 2019, Camille Leahy was excited about the future. She was ready to embark on a new work adventure after quitting her job of 17 years. However, that all changed in January 2020 when she started feeling unwell and was in a great deal of pain. Camille went to the emergency department closest to her home in Newmarket, knowing something just wasn’t right. The next day, she received a devastating diagnosis — acute lymphoblastic leukemia. It was the start of a rollercoaster journey that eventually led her to a Canadian-first CAR T-cell therapy clinical trial taking place at The Ottawa Hospital.

With barely any time to digest the news of her cancer diagnosis, the 35-year-old learned she needed to begin treatment right away. She was referred to Princess Margaret Hospital in Toronto and admitted as soon as a bed was available. “From there, I started a month of treatment that consisted of intense chemotherapy to get me into remission. The goal was to then continue maintenance therapy for a couple of years, which would include chemotherapy, steroids, and other medications,” explains Camille.

With this sudden diagnosis and the immediate requirement for treatment, it meant the single mom couldn’t start her new job — now she was also without employment. “At that point, we just had to worry about saving my life,” says Camille.

Shocking news after rounds of treatment

After 30 days in hospital and all set to go home, Camille received another blow. The treatment didn’t work, and there were still cancer cells lingering. Her medical team needed to try another option — and right away. This time, Camille was put on an immunotherapy drug known as blinatumomab. After a second consecutive month in hospital, away from her daughter, there was a glimmer of hope — she was in remission.

However, she also learned the cancer would keep returning, so her team recommended a stem cell transplant as her best option. “That was shocking news for me,” says Camille.

“About eight months post stem cell transplant, I woke up with some neck pain. I didn't think anything of it, but unfortunately, blood work showed that the cancer returned, and it was aggressive.”

– Camille Leahy

By July 2020, she had undergone the stem cell transplant and spent another month in hospital, but this time, the world was in the midst of the pandemic — that meant her family, including her daughter, couldn’t visit. Camille was eventually discharged, but another hurdle was around the corner. “About eight months post stem cell transplant, I woke up with some neck pain,” explains Camille. “I didn’t think anything of it, but unfortunately, blood work showed that the cancer returned, and it was aggressive.”

“Have you heard about CAR T-cell therapy?”

It was now March 2021, and Camille was out of options. Her medical team recommended another chemotherapy protocol, but she just couldn’t do it. “When they started naming off the types of chemo involved, I broke down because it just sounded all too familiar to my first month, and that induction didn’t work,” recalls Camille. “Also, this time it was during a pandemic. At least when I was diagnosed in January, I had all my family and all my friends visiting every day. But this time around, I wasn’t going to be able to see my daughter, I wasn’t going to be able to have my friends and family as often as I wanted — maybe once a week. I just couldn’t do it without them, I wasn’t strong enough.”

That’s when she remembered CAR T-cell therapy had been mentioned at one point early on, so she asked her doctor about it. “I asked her, ‘Have you heard about CAR T-cell therapy?’ She confirmed there was a trial going on in Ottawa, and she decided to see if I would meet the criteria for it.”

Soon, Camille got the dose of good news she desperately needed – she was accepted into the trial, and she soon met Dr. Natasha Kekre, the principal investigator.

Dr. Natasha Kekre,hematologist for The Ottawa Hospital's Blood and Marrow Transplant Program.

Read our Q&A with Dr. Natasha Kekre

First made-in-Canada CAR T-cell therapy for cancer shows promise

More than a dozen people with cancer who had exhausted all treatment options are alive and cancer free today thanks to a pioneering, Canadian-first clinical trial. It uses a highly personalized kind of immunotherapy to help the patient’s T-cells recognize and kill their cancer. The results to date could open the door to a new era of made-in-Canada immunotherapies for cancer.

Patients in the trial, like Camille, have their immune cells (T-cells) removed and genetically engineered in a lab with a disarmed virus to produce synthetic molecules called “chimeric antigen receptors” (CAR). These new supercharged CAR T-cells, with their enhanced cancer-killing ability, are then infused back into the same patient.

What is the difference between a T‑cell and a CAR T‑cell?

T‑cells are a type of white blood cell, which play a critical role in the immune system. Originating in the bone marrow and maturing in the thymus — a small gland in the chest that’s part of the lymphatic system — T‑cells focus on attacking specific foreign particles, including bacteria, viruses, and other microbes.

CAR T‑cells are T‑cells that have been modified in a lab to fight cancer cells. First, T‑cells are removed from the patient, then they’re engineered to produce proteins on their surface called “chimeric antigen receptors,” or CARs. These proteins help the cells recognize and bind to proteins on the surface of cancer cells. Once engineered, the CAR T‑cells are reinfused into the patient to do their work.

While Health Canada has approved several commercial CAR T-cell therapies, access is currently restricted to people with just a few kinds of leukemia and lymphoma, and only if they fall into certain age ranges. Commercial CAR T-cell therapy is also very expensive and involves shipping cells to the United States and back.

This new trial is the first to manufacture CAR T-cell therapy in Canada. It uses a different kind of cell manufacturing that opens the door to less expensive and more equitable treatment.

“We’re very excited about the preliminary results of this trial, and we will be moving forward with new and exciting trials across Canada.”

– Dr. Natasha Kekre

“Canadian patients deserve access to the best cancer treatments in the world, and we need Canadian research to make this happen,” says Dr. Kekre, who, in addition to her leadership with this clinical trial is also a scientist and hematologist at The Ottawa Hospital. “We’re very excited about the preliminary results of this trial, and we will be moving forward with new and exciting trials across Canada.”

CAR-T trial provides one last shot

Camille’s cancer journey up until this point experienced many hurdles and that happened once again with the CAR-T clinical trial. During the first attempt, she was sent back home because she had a lung infection. By the second try, Camille was having some neurological symptoms that included her face going numb. “The medical team decided to investigate, and they did a lumbar puncture that showed the cancer had gone into my central nervous system and they hadn’t been able to detect that because there’s a blood-brain barrier. Again, I was sent home,” recalls Camille.

“Obviously when I was told that this was my last shot I was terrified. I knew there were risks, but my options were limited. I took a chance, but I also know how passionate Dr. Kekre is about this trial. I did a lot of research about CAR-T and how effective it was.”

– Camille Leahy
Camille with her daughter, Michela.

She would have to endure lumbar punctures twice weekly with chemotherapy to clear the cancer from the central nervous system — something Camille describes as “awful”, but she didn’t give up.

Finally, Camille got the green light for a third trip to Ottawa, but the day before she spiked a fever. She remembers telling her family, “I know that there’s a chance I might not be able to do it, but I’m going anyway.” Somehow, the fever cleared and finally the team was able to go ahead with the cell collection.

Two weeks later, on September 15, 2021, she had the CAR T-cells reinfused into her body — reprogrammed to now be able to recognize the cancer cells and kill them.

Camille and her daughter waited to see if, finally, they would get good news. “Obviously when I was told that this was my last shot, I was terrified,” explains Camille. “I knew there were risks, but my options were limited. I took a chance, but I also know how passionate Dr. Kekre is about this trial. I did a lot of research about CAR-T and how effective it was.”

Immunotherapy research changes lives

It has been a long and challenging journey for Camille, but she is truly grateful to the entire team at our hospital who were ready to care for her when she had run out of treatment options. It wasn’t until one year after Camille’s CAR T- cell treatment that she really started to believe she could get better. After so many hurdles during this cancer journey, she knew it would take time and wanted to give it a year.

By September 15, 2022, she felt like a new person, and was cancer-free. “I’m back to driving, I’m back to feeling as normal as I can. Obviously, there’s always the fear, but I couldn’t walk last year. I was using a cane and a walker. I struggled a lot. But this trial changed my life.”

“Even if the cancer comes back, this has given me precious time, and I know the research will help many others. It has given me a fighting chance.”

– Camille Leahy

As Camille and her daughter, Michela, are back to doing the mother-daughter things they love, Camille is also advocating for the research that saved her life with the end goal of giving more patients hope. She wants to make sure CAR T-cell therapy is available to others who face an uncertain future like she did. “For it to become more widely available in Canada would be incredible. The research team at The Ottawa Hospital made it possible for me to have this treatment done here in Canada. I didn’t have to raise money to try and leave the country to go get CAR T-cell treatment in the United States. My goal now is to tell my story so that they can continue to do this in Canada and can become more available to everyone here.”

Today, at age 38, Camille is easing back into life and thinking about the future. When her immune system is strong enough, she hopes to return to work. Right now, she enjoys the precious time and memories she’s been given the opportunity to make with her daughter, like driving her to school, taking her to baseball games, and watching her play soccer — moments she doesn’t take for granted. “Even if the cancer comes back, this has given me precious time, and I know the research will help many others. It has given me a fighting chance.”

Download episode #75 of Pulse Podcast to hear Camille talk about why she’s become an advocate for cancer research.

Listen Now:

The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.

Shaping Ottawa’s landscape through construction and philanthropy

Urbandale Corporation and the Nadolny and Sachs families donate $7 million to the Campaign to Create Tomorrow to help ensure the city they love has the healthcare our region deserves

Few deals these days are done over a simple handshake. But when you’ve garnered the kind of trust that Herbert Nadolny and Lyon Sachs did, that’s all it took. The two school chums, who first met in Grade 7 at York Street Public School, were lifelong friends who would forge a bond that would last through the decades. That bond would give rise to a company called Urbandale that, today, is as successful and strong as the day Herb and Lyon shook on their very first deal.

“We didn’t know anything about building,” Lyon Sachs once said, describing the land they had just bought that would become Urbandale Acres. “There was a ditch and a two-by-ten plank of wood that I walked across. Then Herbie tried and fell into the ditch and the mud.”

It was clear, even from that moment, that Herb and Lyon were visionaries who could look at a muddy plot of land and see the potential it held.

Lyon Sachs and Herbert Nadolny.

And as their company has grown over more than 60 years and continues to grow, so has their vision — to create strong, welcoming neighbourhoods, while also bettering our community through philanthropy. 

“For more than 60 years, the Urbandale philosophy has been about building a community and being active members of that community. This will continue to be our focus well into the next century,” says Richard Sachs, Lyon’s son.

Sadly, Herb passed away in 2005, but the Nadolny and Sachs families remain deeply involved with our community and honour both Herb and Urbandale’s special legacy. As a family and as a company, they’ve contributed to a wide range of causes, from the arts and education to food banks and the Ottawa Jewish Community Foundation. Their generosity and passion, however, know few bounds when it comes to the healthcare needs of our community.  

“We had no choice!” laughs the family as they share how they felt an overwhelming need to give back to the very hospital where Lyon was born in 1927. 

“We are proud to live in this city and are grateful for the ways the hospital has cared for our families, our employees, and our clients. This gift is our way of giving back.”

— Richard Sachs

“It’s critical for us to pave the way for the next generation. We need to support the hospital and all the services they provide,” says Richard. “We are proud to live in this city and are grateful for the ways the hospital has cared for our families, our employees, and our clients. This gift is our way of giving back.” 

They are, indeed, doing that and more with their recent gift of $7 million to the Campaign to Create Tomorrow. Even though their preference is to remain firmly behind the scenes, the Nadolny and Sachs families hope by stepping forward they can lead by example and encourage others to give. 

“It’s how we were raised and how we are raising our children and grandchildren,” says Sharon Weinstein, Herb’s daughter, who proudly shares that giving back is something every single member of their two families have been taught to do for generations.   

The $500-million Campaign to Create Tomorrow sets in motion a vision to transform how the world delivers healthcare — by building the most technologically advanced hospital in Canada and taking groundbreaking research and innovation to unprecedented heights. 

When the New Campus Development opens in 2028, it will be 70 years since Herb and Lyon founded Urbandale. They have inspired us to focus on the importance of community. And, with this gift, they continue to inspire us to focus on the community’s need for healthcare. 

Thank you, Urbandale and the Nadolny and Sachs families, for your transformational leadership and your ongoing dedication to our community.

About the Campaign to Create Tomorrow

The Campaign to Create Tomorrow is the largest fundraising campaign in our region’s history. It will help fulfil the most ambitious vision ever for the future of The Ottawa Hospital, focused on four critical pillars.  

INNOVATION & TECHNOLOGY

See how we’ll become the most technologically advanced hospital in the country, using the latest tools to provide the right care in the right space with the right provider.
Learn More

WORLD LEADING RESEARCH

Through our unique collaborative model of clinicians and researchers working side-by-side, we will bring groundbreaking discoveries to patients in Ottawa — and around the world.
Learn More

STRENGTHENING CRITICAL SERVICES

From trauma care to cancer advancements to neuroscience, we will strengthen our critical services for patients across the region.
Learn More

CTV News Coverage — Graham Richardson reports that construction for the new hospital campus parking garage is getting underway.

For Sol and Zelaine Shinder, the Jewish concept of tzedakah — of giving back — holds great significance. Throughout their long tradition of generosity in the community, including to The Ottawa Hospital, there have been certain numbers, milestones you could say, that hold significance and help paint the picture of their legacy.

For example, they have just welcomed their 409th family member to the Shinder family tree. Each time someone joins the family, either through birth or marriage, they are presented with a special Shinder t-shirt, emblazoned with a photo of Sol’s grandfather.

Then, there’s the incredible 62 years that Sol and Zelaine have been married. In those years, they’ve welcomed two children and five grandchildren, several of whom were born at the Civic Campus.

The Civic is set to celebrate its own significant milestone when it turns 100 in 2024. It was built the same year that Sol’s grandfather moved his family to Canada. It was a decision that would be as fortuitous for Sol and Zelaine as it would be for Ottawa. The Shinders’ commitment to community reaches far back into the family history, with both Sol and Zelaine having been taught the importance of tzedakah.

“Excellent hospitals are the very fabric of every great city. It is critical that we have outstanding healthcare and education in Ottawa to attract the very best talent and provide the very best care.”

— Sol Shinder 

“We can only help by becoming involved and helping ourselves,” Sol Shinder has said. And they have truly lived by those words.

Sol served 12 years on the Board of Governors of The Civic Hospital and was Chair of the board during the 1998 amalgamation of all three Campuses — remaining on as one of only four founding trustees. Sol first became involved because of his deep desire to help patients and improve care. This still holds true today.

Sol was a longtime volunteer in the Jewish Community and was President of the Vaad Ha’Ir (now the Jewish Federation of Ottawa) from 1979 to 1981. In 1986, the community awarded Sol its highest honour — the Gilbert Greenberg Distinguished Service Award. Zelaine shared this deep commitment to community as a lifelong volunteer, teacher, and then founder and director of the Jewish Resource Centre, which provided Judaic teaching aids to Ottawa’s public and private schools. Having followed in the footsteps of their parents, whom they describe as community builders, Sol and Zelaine have in turn instilled those same philanthropic values in their children and grandchildren — creating an ongoing legacy of tzedakah.

And so, there is one more number that tells the story of the Shinder family and marks an important milestone in their continuing impact on the community. In the Jewish faith, 18 stands for “chai” or “life.” It is an omen of good luck and prosperity. And for that reason, Sol and Zelaine have pledged $180,000 to the Campaign to Create Tomorrow — a lifeline of luck they hope will inspire others to donate.

For the Shinders, the future will undoubtably see new family members welcomed into the fold, more anniversaries celebrated, and new milestones created. But most importantly, their legacy of leadership and generosity will continue to make a lasting impact on our community.

Growing up in a military family, Janet McKeage was always on the move. While the cities changed, her family’s open-door policy remained the same. Her parents were always ready to help others and give back, and to this day, she credits them for instilling that core value she and her husband now share with their four children. “My parents didn’t have a lot of money, but they taught me the importance of helping the people around you in any way that you can. Often, there were young military members who didn’t have family nearby, and they were always welcome at our dinner table — we’d often have many people joining us for a meal,” recalls Janet. 

When she was in her early 20s, Janet lost her father to pancreatic cancer. He died several months after his diagnosis, but Janet vividly recalls the care and compassion he received from his team of specialists here at The Ottawa Hospital. Then, almost ten years ago, another devastating blow — Janet’s dear friend, Sindy, was also diagnosed with pancreatic cancer. “So that’s what brought me to support the hospital. I knew my dad had had great care. And I had a very dear friend that needed the same great care my dad received. Then, when I grew to learn more about the research side of the hospital, I was really blown away.” 

“When I think about success for anyone in life, the most important thing is health — having a hospital in our city that is full of leading research, new discoveries, new treatments and having the best care that we can possibly have — it’s critical.”

– Janet McKeage

Today, as Senior Investment Counsellor, RBC PH&N Investment Counsel, Janet feels very fortunate to have a career that has spanned 30 years with RBC. It aligns closely to her own philanthropic values by helping families with their own health and wealth investments. Janet is quick to point out how closely the two are intertwined and that’s what influences her own philanthropic leadership for The Ottawa Hospital. “When I think about success for anyone in life, the most important thing is health — having a hospital in our city that is full of leading research, new discoveries, new treatments, and having the best care that we can possibly have — it’s critical.” 

“It’s not about being involved with an organization because it looks good on your resume. It’s about really caring and doing things that are meaningful.”

– Janet McKeage

While supporting the hospital is one thing, Janet also took action. It started by running with Sindy’s #MEMC (Make Every Moment Count) Crew as a part of Run for a Reason. Next, she became a volunteer and then co-chair of our President’s Breakfast, then joined our Foundation’s board of directors, and in June 2022, became chair. “It’s not about being involved with an organization because it looks good on your resume. It’s about really caring and doing things that are meaningful. This role as chair of The Ottawa Hospital Foundation is a bit of a culmination of all the things that matter and allows me to bring some of my business background, my volunteering and dedication to something that I’m passionate about. I believe the hospital is critical and core to any successful community, to any family. Let’s face it, if people haven’t experienced the hospital to this point in their life, they certainly will one day, and I want to make sure that it’s the best for everyone.” 

That’s why Janet is stepping forward for our GivingTuesday campaign on November 29, 2022, with a commitment to match each gift 3X up to $100,000.

Janet is more motivated than ever after recently learning Sindy’s cancer has returned. “It’s philanthropy that’s helped with the incredible care Sindy has received. It’s been almost 10 years since her initial diagnosis, and I’m grateful for every day. More research is needed to give people, like Sindy, hope for a better outcome,” explains Janet. 

While Janet pushes forward to help build support for our hospital. She also keeps the powerful message of her dear friend close to heart — make every moment count.   

Cyril Leeder and Janet McKeage, co-chairs of the President’s Breakfast for The Ottawa Hospital from 2018-2020.
2022 President’s Breakfast Co-Chair Sarah Grand with Janet McKeage, Chair of The Ottawa Hospital Foundation’s Board of Directors. Photo by Ashley Fraser

Published: November 2022

When caring for patients who suffer from a stroke — time is of the essence. In Canada, stroke is the third leading cause of death and disability in adults, but an innovative and ever-evolving stroke treatment, called thrombectomy, used at The Ottawa Hospital, is a game changer. The Ottawa Hospital is recognized worldwide for expertise in neuroscience, and we’ve made significant strides in addressing today’s most pressing challenges in neuroscience — including our international, groundbreaking work in stroke. In fact, we are leading the way in how stroke care is delivered in Canada, including the use of thrombectomy.

Ten years ago, a thrombectomy was an experimental stroke treatment — with life-altering potential. Dr. Robert Fahed was a medical student doing his residency program in neurology at a prestigious hospital in Paris, France, when he was first introduced to this novel procedure. In fact, he vividly recalls the results from the first thrombectomy he witnessed. “A woman in her 50s suffered a massive stroke. Her right side was paralyzed, and she was unable to speak because of the stroke. Unfortunately, she wasn’t a candidate for a drug used to dissolve the clot in the brain,” explains Dr. Fahed. “I thought to myself, this poor woman will be paralyzed for the rest of her life, if she survives.”

That’s when a member of the care team explained they were going to try an experimental treatment called thrombectomy. Dr. Fahed continued with his rounds and 30 minutes later, he received a shocking call. “The patient was moving her right arm. She wasn’t paralyzed anymore. I immediately thought, ‘I don’t know what happened in that room, but I want to be the one doing these interventions. I want to be the one bringing those people back to life. That’s what I want to do.’”

Attracting the best and brightest from around the world

Today, Dr. Fahed is one of only four interventional neuroradiologists and stroke neurologists in Canada. He was recruited to The Ottawa Hospital in 2019 — fulfilling his childhood dream of coming to live in Canada.

His parents immigrated to France from Syria before he and his sister were born, hoping for a better life for their children. Growing up in the suburbs of Paris, Dr. Fahed watched his father, a neurologist, care for patients day in and day out. And so, the field of neurology was a natural path for him to follow. “I’ve always liked neurology. It was pretty clear to me that I wanted to become a doctor. I was seeing my father as my hero. One of my very first electives was in stroke neurology.”

“The Ottawa Hospital is famous for its expertise in stroke. We have a very strong stroke program, and are a high-volume centre where we perform these treatments 150 to 200 times a year.”

— Dr. Robert Fahed
“The Ottawa Hospital is famous for its expertise in stroke. We have a very strong stroke program, and are a high-volume centre where we perform these treatments 150 to 200 times a year.”

— Dr. Robert Fahed
Meet Dr. Fahed

What are the symptoms of a stroke?

Dr. Fahed did most of his training at the Rothschild Hospital in France, which he describes as one of the centres where interventional neurology was pioneered. But this young physician also had a deep desire to do research, so he completed a master’s degree in Montreal before returning to Paris — but always longed to come back to Canada. “The Ottawa Hospital is known for its great research infrastructure and how much it supports researchers.” 

New technology changes the outcome for stroke patients

One-quarter of Canadians living with stroke are under age 65, and the risk of stroke rises rapidly after age 55. Eighty-seven percent of all strokes are ischemic strokes — when a vessel supplying blood to the brain is blocked by a clot.

The late Dr. Cheemun Lum and Dr. Dar Dowlatshahi helped pioneer a technique called endovascular thrombectomy (ET) that saved the lives of numerous stroke patients. The findings from the trial known as ESCAPE were released in 2015. This unique procedure is performed by inserting a thin tube in the groin, where it travels through an artery until it reaches the clot in the brain. With the help of X-ray technology, the clot is then sucked out with the help of a pump, restoring blood flow to the brain.

“We're aiming to remove the clot completely, on the first try. We call it a home run.”

– Dr. Robert Fahed

While this was a groundbreaking procedure, more work was needed to better perfect it as they could only re-open the blocked artery 50 to 60% of the time. “That clot is not always easy to remove. Sometimes you need to try multiple times. Sometimes you can only remove part of it. If you can only partially reopen the vessel, you only partially restore blood flow, which means that some regions of the brain will be damaged. So, we’re aiming to remove the clot completely, on the first try. We call it a home run,” says Dr. Fahed.

These home runs are becoming increasingly common thanks to new technology — and the results can be lifechanging. A patient can go from being paralyzed and unable to speak to talking and walking within 20 minutes of the procedure.

How can you check if someone is having a stroke?

If you suspect someone is having a stroke, experts recommend using the F.A.S.T. method.

How we helped refine the technology to provide better outcomes

Recently, a new catheter device developed by a start-up in Kitchener-Waterloo showed promise at removing the clot on the first try. The company reached out to our stroke team for help in testing the effectiveness of the Health Canada approved equipment. “The Ottawa Hospital is famous for its expertise in stroke. We have a very strong stroke program and are a high-volume centre where we perform these treatments 150 to 200 times a year,” says Dr. Fahed.  

He adds, “We also have unparalleled scientific expertise in the design of studies to evaluate these tools. Because when you create a tool, you can’t just use it. You need to try it, evaluate it, and see if it’s safe and efficient. So, the company approached me and Dr. Brian Drake to investigate.” 

They used 3D-printed silicone models to test this new stroke treatment option using fake clots in 3D-printed blood vessels that mimic a brain. They spent many hours trying different ways to use this catheter. “We wanted to determine the best and most effective way to use it in patients, and we found an approach that was very promising and extremely efficient in the silicone model. Then we designed a study that uses the catheter in stroke patients, and we will compare the results of this trial with trials using different tools and devices,” says Dr. Fahed.  

"If the results continue this way, it's a major game changer. It's going to be a huge revolution in this field.”

– Dr. Robert Fahed

So far, the results are extremely promising. The success rate of pulling the clot out on the first try — the ‘home run’ — has increased significantly since using this newly devised catheter. “We are now able to pull the clot out completely on the first try in the vast majority of patients. If the results continue this way, it’s a major game changer. It’s going to be a huge revolution in this field.” 

What’s the connection between COVID-19 and strokes?

COVID-19 has been found to cause neurological complications, not just respiratory issues. Early studies show that COVID-19 could more than double the risk of a stroke, especially in people with other risk factors. Multiple studies have shown even young people are at a higher risk of stroke because of COVID-19. People who experience a stroke with COVID-19 are also at a higher risk for death or disability.

Disruptive innovations and treatments thanks to research

Dr. Robert Fahed_neuroradiology_The Ottawa Hospital_profile

“I'm proud to be part of such disruptive innovations and treatments — there is a lot of excitement in our field because the future is even brighter.”

– Dr. Robert Fahed

This treatment could be transformative for stroke patients and their families, and it if it continues to be successful, the benefits will be felt across the country impacting thousands — saving the lives of more people and saving them from disability. “I’m proud to be part of such disruptive innovations and treatments — there is a lot of excitement in our field,” smiles Dr. Fahed. 

Research plays a vital role in where we are today and the innovative advancements we’ve seen to date. “Today’s research is tomorrow’s care. What we are studying today will be the cutting-edge, groundbreaking, disruptive treatment that we can offer to our patients tomorrow,” explains Dr. Fahed.

His constant search for new stroke treatment options continues in the research he does today. Dr. Fahed is currently assessing whether algorithms used to determine which people are eligible for thrombectomy may be missing some patients. He’s testing these algorithms to make sure they give the same answers when assessed by different physicians or machines. There’s also research into the type of drugs to give stroke patients when they’re with paramedics, prior to the arrival at the hospital.  

Patient Testimonial
Mary Vanstone arrived at the Civic Campus of The Ottawa Hospital on September 27, 2022, after suffering a stroke at her home in Perth, Ontario.
Patient Testimonial
The ischemic stroke had completely paralyzed her left side. Dr. Robert Fahed was in the Interventional Neuroradiology Angio suite that afternoon and performed a thrombectomy on Mary shortly after her arrival.
Patient Testimonial
“They initially didn’t know what the long-term effects would be for me physically and even my brain when I first arrived. But I’m even better than I was before. They said I would likely be in for a week, but the next day, after the procedure, they said I could go home — everything was good! The hospital was fantastic. It was amazing.”

– Mary Vanstone
Previous
Next

According to Dr. Fahed, the future is bright, rapidly changing, and improving the lives of more patients. “The pace of evolution and improvement is exponentially higher and better every year. My job is already so different than what it was 10 years ago when I started. And 10 years from now, it will be a completely different field. We will be doing so many more things and doing them so much better.”

It’s a world that continues to fascinate this physician, much like that first thrombectomy he witnessed years ago.

“Today's research is tomorrow's care. What we are studying today will be the cutting-edge, groundbreaking, disruptive treatment that we can offer to our patients tomorrow.”

– Dr. Robert Fahed

Key stroke stats and facts

The Ottawa Hospital is a leading academic health, research, and learning hospital proudly affiliated with the University of Ottawa.

The true leaders in a community are those who step forward when they hear the call for help, use their position to lift up those around them, and inspire others to do the same.

It is that kind of leadership that drives the Mierins family to give back in significant ways.

Lisa Mierins says her family has personally experienced exceptional care at The Ottawa Hospital over the years, especially when both her parents required hospitalization. In fact, her father, Arnis, was on life support twice in the years before he passed away in 2020. “Both the Emergency Department and Intensive Care Unit teams were unbelievable. They took good care of all of us and took us by the hand at a very difficult time.”

“The Ottawa Hospital is leading the way in the future in healthcare, and we all need to do our part.”

— Lisa Mierins

That compassionate care is what inspires their family to support The Ottawa Hospital — and now, they are using their leadership to motivate others in the community to join them.

From November 1st until December 31st, 2022, the Mierins Family Foundation will match all one-time donations up to a total of $1 million. They hope the opportunity to have a gift doubled will inspire others who recognize the importance of The Ottawa Hospital in our community and the connection we all have to the high-quality care it provides.

“The Ottawa Hospital is leading the way in the future in healthcare, and we all need to do our part,” says Lisa. “Right now, we have an opportunity to move our hospital — and our community — forward.”

The Mierins Family Foundation was created in 2018 with Lisa and her brother, Arnie Mierins, at the helm as co-presidents. The team also includes her sister-in-law, Victoria Mierins, and one of Lisa’s sons, Patrick Bourque. Philanthropy has long been a core value of the family with their strong desire to support their community. And with this most recent gift, they hope to see their family’s $1 million transformed into $2 million for the hospital.

Arnie and Victoria Mierins
Arnie and Victoria Mierins
Lisa Mierins and her son, Patrick Bourque
Lisa Mierins and her son, Patrick Bourque

“The Ottawa Hospital has treated us like family. They’ve been amazing to us, so we wanted to do something in return for them. We’ve been very blessed in our lives, and this is our way to give back to the community,” says Lisa.

“It is our obligation to do something, and big or small, every donation counts. The Ottawa Hospital was there for my family, and we know how comforting it is to be in a great facility that cares and goes beyond expectations.”

— Lisa Mierins

She adds it’s an opportunity for community members to double their donation and have a bigger impact—no matter what the size of gift. “It can be a $10 donation, which then becomes a $20 donation.”

“Every great city needs a state-of-the-art hospital,” says Lisa. “It is not an option to do nothing. It is our obligation to do something, and big or small, every donation counts. The Ottawa Hospital was there for my family, and we know how comforting it is to be in a great facility that cares and goes beyond expectations.”

Updated: February 2024

Nearly three years after undergoing groundbreaking immunotherapy for stage 3C colorectal cancer at The Ottawa Hospital, Haydn Bechthold is making strides — he’s currently in his second year of law school in Toronto and will spend another summer at Emond Harnden, a law firm that has supported our President’s Breakfast.

Published: October 2022

As a young athlete playing semi-pro soccer overseas and going to school, Haydn Bechthold admits he felt invincible. But a diagnosis of colorectal cancer at age 22 quickly changed that perspective. The news was a shock, not only to Haydn but also to his family and friends. He was young, active, and otherwise healthy, so a diagnosis of stage 3C rectal cancer was hard news to digest. “I remember thinking ‘Don’t Google survival rates,’” recalls Haydn.

When Haydn was referred to The Ottawa Hospital Cancer Centre, there was a full team assembled. He met with medical oncologist Dr. Joanna Gotfrit, followed by radiation oncologist Dr. Jenny Jin, and surgical oncologist and Director of Cancer Research, Dr. Rebecca Auer. He learned there was some good news — the cancer hadn’t spread.

Dr. Joanna Gotfrit is a medical oncologist at The Ottawa Hospital.

Dr. Jenny Jin is a radiation oncologist at The Ottawa Hospital.

Dr. Rebecca Auer is the Director of Cancer Research at The Ottawa Hospital.

A most unusual case of colorectal cancer

For Dr. Gotfrit, the first thing she remembers after learning about Haydn’s case was how unusual it was to have a patient his age with this kind of a diagnosis — typically, patients are decades older. “No matter the age, whether it’s a very young patient or someone who’s elderly, it’s never easy to deliver bad news. But there is an extra layer and challenge when patients are that young. It’s life-altering, no matter how the trajectory goes,” explains Dr. Gotfrit.

Haydn Bechthold was treated for rectal cancer at The Ottawa Hospital.
Haydn Bechthold was diagnosed with colorectal cancer at age 22.

When Dr. Auer left the exam room after meeting Haydn for the first time, she remembers feeling heartbroken, thinking about this young man’s life, his future, and the diagnosis he faced. The standard form of treatment for Haydn was radiation, chemotherapy, and surgery — each one would impact his life. He faced infertility, life with an ostomy bag, and the likelihood of recurrence. “That was hard, but having access to cutting-edge care, we quickly started to think outside the box. I called Drs. Gotfrit and Jin, and we decided to get molecular testing on his tumour,” explains Dr. Auer.

“We knew there was a strong chance we were going to find some rare molecular alterations in his tumour that may drastically change how we would want to approach this case.”

– Dr. Joanna Gotfrit

Those molecular markers from testing would be key to determining the path forward for Haydn’s treatment. Dr. Gotfrit explains while they had the diagnosis and knew the stage of his cancer, there were still underlying questions. “We knew there was a strong chance we were going to find some rare molecular alterations in his tumour that may drastically change how we would want to approach this case. And when I say that, I mean, it may open other avenues of treatment for him.”

Those molecular markers from testing would be key to determining the path forward for Haydn’s treatment. Dr. Gotfrit explains while they had the diagnosis and knew the stage of his cancer, there were still underlying questions. “We knew there was a strong chance we were going to find some rare molecular alterations in his tumor that may drastically change how we would want to approach this case. And when I say that, I mean, it may open other avenues of treatment for him.”

Navigating through the cancer journey

As Haydn and his family came to terms with the diagnosis and attended a multitude of tests and appointments, there was one constant: Mary Farnand — his nurse navigator.

A nurse navigator is a specialized oncology position. Mary works in the Cancer Assessment Clinic (CAC), and along with other nurse navigators at our hospital, is the first point of contact for patients who are being diagnosed. “We review the patient’s history, and initiate some of the work-up, such as bloodwork and scans, to make sure it goes as fast as possible and is personalized,” explains Mary.

“It’s a very difficult time in their life. Our role is to try and provide clarity as well as emotional support.”

– Mary Farnand

The CAC provides a central source of information, support, and advocacy for patients. “We receive referrals, review them, and try to understand what the patients need. We help patients manage symptoms, and if they live farther away, can we direct their scans to another hospital closer to home. We are that source of consistency for each patient,” explains Mary.

This role quite literally helps the patient and their family move through the cancer program and better understand what lies ahead. “We navigate with the patient, giving them as much information as possible to help inform their treatment decisions. It’s a very difficult time in their life. Our role is to try and provide clarity as well as emotional support,” says Mary.

Haydn and Mary Farnand at The Ottawa Hospital’s President’s Breakfast.

Photo by Ashley Fraser.

The CAC provides a central source of information, support, and advocates for patients. “We receive referrals, review them, and try to understand what the patients need. We help patients manage symptoms, and if they live farther away, can we direct their scans to another hospital closer to home. We are that source of consistency for each patient,” explains Mary.

This role quite literally helps the patient and their family move through the cancer program and better understand what lies ahead. “We navigate with the patient, giving them as much information as possible to help inform their treatment decisions. It’s a very difficult time in their life. Our role is to try and provide clarity as well as emotional support,” says Mary.

Haydn is adamant he couldn’t have done any of this without her. “She was such a huge help and so kind to me through this whole process. I remember having so many people contacting me early on and it was quite overwhelming, but Mary was always there. She was always willing to help me figure out what my next move was going to be. She was my constant source of support.”

That support would continue as Haydn’s team got a clearer picture of what kind of tumour they were dealing with.

When should I be tested for colorectal cancer?

People who have an average risk of colon cancer should start getting screened regularly at 50. For those with a higher risk — due to family history, a personal history of chronic inflammatory bowel disease, or other risk factors — it might be recommended to get screened earlier or more often.

Early signs of colon cancer include: persistent changes in bowel habits (unusual diarrhea or constipation), rectal bleeding or blood in stool, persistent abdominal discomfort, a feeling of incomplete bowel movements, weakness or fatigue, and/or unexplained weight loss. If any of those symptoms appear alone or together and persist, seeing a doctor is recommended.

Molecular Oncology Diagnostics Lab plays a key role

Further testing helped the care team plan the best course of treatment for this young man. Some of that testing happened at The Ottawa Hospital’s Molecular Oncology Diagnostics Lab — a first-of-its-kind in Ottawa.

The donor-funded lab is revolutionizing cancer diagnosis and treatment by allowing healthcare providers to analyze the genetic flaws inside tumour cells and tailor therapies to a patient’s individual type of cancer. This improves cancer care by giving care teams the ability to predict which drugs would work best for that particular patient’s illness and which drugs would not be beneficial.

Research conducted in the lab gives patients access to the latest experimental cancer therapies before they are available elsewhere. It’s the third lab of its kind in Canada to use the most advanced genetic analysis technology — next-generation sequencing — to analyze patterns from large groups of genes or proteins. The end goal is to improve the detection and control of cancer with more precise treatments customized for each patient.

Haydn and Dr. Auer at The Ottawa Hospital’s President’s Breakfast.

Photo by Ashley Fraser.

“Haydn got this cutting-edge treatment about one year before the world knew anything about it. This was because we have a highly knowledgeable and courageous team that decided to think outside the box for a 22-year-old with cancer.”

– Dr. Rebecca Auer

As Haydn’s team awaited the results of his testing, he was prepping for radiation which was set to begin in March 2021. But as the day approached for his first treatment, he got a call that would change everything. “It was a conference call unlike any I’ve ever experienced. All three of my doctors were on the line. They explained biomarker testing on my tumour showed I had what’s known as MSI-H cancer, which meant I was eligible for a certain type of immunotherapy treatment,” recalls Haydn.

This unique sub-type of rectal cancer has responded well in clinical trials to immunotherapy. As the team explained to Haydn and his family, they used data from the literature to come up with an individualized treatment plan — one they believed would give him the best long-term outcome. “Haydn got this cutting-edge treatment about one year before it was widely known. This was because we have a highly knowledgeable and courageous team that decided to think outside the box for a 22-year-old with cancer,” explains Dr. Auer.

Testing also revealed Haydn had Lynch syndrome — an inherited condition that increased his risk of certain cancers, including colorectal cancer. These test results were valuable information that allowed his care team to develop a personalized treatment for his unique case. They believed immunotherapy would give Haydn the best chance to live a long, healthy life.

The hope of immunotherapy

When Haydn was presented with this alternative to the standard of care, he was excited, but also nervous. “While I was nervous to try something new and futuristic like this, I was also excited by the hope immunotherapy offered me. My family and I had complete faith in my doctors, knowing they could access this treatment, which had been successful in very early studies,” says Haydn.

“The scan showed my tumour had shrunk by almost half. It was incredible.”

– Haydn Bechthold

For Dr. Gotfrit, being able to offer Haydn this treatment option was a game changer. She recalls just eight to 10 years ago, as an internal medicine resident rotating through oncology, there was very little personalized medicine. However, that is changing rapidly. “More and more data, discoveries, and developments about the molecular basis of tumours are coming to light. And, importantly, drugs that could directly target those molecular alterations are being developed. So instead of chemo that essentially ‘shoots to kill’ any rapidly dividing cells in a very nonselective way causing a multitude of side effects everywhere in the body, we’re now developing therapies that are much more selective and can directly target specific mutations in tumours. Being able to identify these molecular alterations is a huge step forward for oncology, giving us more options with a better quality of life. So, it’s a win on all accounts.”

On April 1st, 2021, Haydn started immunotherapy treatment. Within a month of treatment, all of Haydn’s symptoms were gone. No more blood in his stool, no more pain, his energy was back, and he was no longer losing weight.

What is immunotherapy?

Cancer immunotherapy, or immuno-oncology, is a treatment that harnesses a patient’s own immune system to fight their cancer. It works by “training” the immune system to recognize and attack cancer cells, strengthening immune cells to fight cancer, and/or helping the body boost its immune response in other ways. There are many different forms of, and ways to deliver, cancer immunotherapy, including targeted antibodies, vaccines, cell transfers, viral therapies, and more. Cancer immunotherapy is a biotherapy, and it might be used on its own or in combination with other treatments, like surgery, chemotherapy, or radiation.

The news got even better with his first scan two months after treatment began. It was news Haydn was thrilled to hear. “The scan showed my tumour had shrunk by almost half. It was incredible.”

Ready for J-pouch surgery

The immunotherapy treatment continued until July 2021. At that point, the tumour couldn’t be seen on the latest scans and that’s when Dr. Gotfrit called Dr. Auer to say this young man was ready for surgery.

By August, a major operation was planned to remove the remaining signs of the tumour and the surrounding lymph nodes. Haydn also underwent a procedure known as J-pouch surgery. This would remove his entire colon to help eliminate any future risk of cancer, while also allowing him to live a normal life without an ileostomy bag. It was during this surgery that Dr. Auer made a remarkable discovery — there were no signs of cancer. “This was a really wonderful moment. Thinking back to the day I met him, and I thought for sure he was going to break my heart, here we were with a really amazing outcome. This was a young man who potentially had his whole future back,” says Dr. Auer.

Once the J-pouch healed, Haydn was back in the operating room in November of 2021, this time with Dr. Shaheer Tadros and Dr. Auer to remove the temporary ileostomy and finish the J-pouch procedure. He was about to get his life back.

How J-pouch surgery works

BEFORE SURGERY

  • Colon and rectum present
  • Patient suffering from symptoms

DURING SURGERY

  • Colon and rectum removed
  • J-shaped pouch constructed from small intestine and attached to anus
  • Ileostomy bag placed during surgery to help with the healing of the pouch

SECOND-STAGE SURGERY

  • Ileostomy bag reversed
  • POST SURGERY J-pouch and anus fully functioning

The role research plays in changing the course of cancer care

When faced with a challenging cancer case, our cancer experts didn’t settle for the standard of care — knowing the long-term impact it could have on Haydn’s life. Instead, they dug deep and offered him an alternative with better long-term quality of life — immunotherapy treatment.

Since starting her own research laboratory at The Ottawa Hospital in 2007, Dr. Auer has focused on the interplay between cancer, surgery, and the immune system — making many important discoveries. “Surgery is very effective in removing solid tumours. However, we’re now realizing that, tragically, surgery can also suppress the immune system in a way that makes it easier for any remaining cancer cells to persist and spread to other organs.”

Dr. Auer’s team has discovered how this happens and they are now testing different strategies in the lab and in patients to modify the immune system and prevent cancer from coming back after surgery. These trials often include patients with colorectal cancer.

Just a few years ago, Haydn never gave much thought to research, let alone cancer research, but his views are very different today. “There are so many advances every year in this field, especially clinical trials, it’s really exciting. I think a lot of people hear the term clinical trials, myself included when I was in treatment, and are quite scared. But a lot of the time, it’s the most up-to-date or newest form of treatment and possibly the best, so the importance of research is massive.”

Setting his sights on the future

Just a few months after Haydn’s second surgery he started feeling like his old self. He began exercising again and putting on weight. Incredible progress in a very short time after his shocking diagnosis.

Today, Haydn continues to be monitored closely by Dr. Gotfrit, and will be for the next few years, but the cancer is gone and he’s getting back his life. As far as his medical oncologist is concerned, that’s the best possible outcome she could have imagined for him. “This is exactly why you go into medical oncology. It’s the absolute best feeling in the world to put in all that effort, thought, and agonize over what’s the right thing to do for this young man. And then make the best decision possible and see that it worked as well as or better than you ever could have imagined. It’s hard to describe how good that feels,” says Dr. Gotfrit.

The Ottawa Hospital’s President’s Breakfast was held Tuesday, Sept. 13, 2022, at the Canadian War Museum.

Mary Farnand, Dr. Auer, Haydn and his parents at The Ottawa Hospital’s President’s Breakfast.

Photo by Ashley Fraser.

“I also realize how incredibly fortunate I was to have The Ottawa Hospital and this team of doctors who wouldn’t settle for traditional treatments — who thought outside the box to give me the best life possible.”

– Haydn Bechthold

For Haydn, it’s a team effort he won’t soon forget. “I never worried about death before this, but I realized I’m not invincible. I also realize how incredibly fortunate I was to have The Ottawa Hospital and this team of doctors who wouldn’t settle for traditional treatments — who thought outside to box to give me the best life possible. I felt like they all really cared.”

Now living in Toronto and going to law school, you can still find Haydn kicking the soccer ball around for fun, and he says with a smile that he might not be done with soccer yet. Now he has time on his side to make that decision.

Listen to Haydn share his story in his own words in episode 69 of Pulse Podcast.

Listen Now:

An unwavering drive to help others leads to generous donation

Longtime nephrologist Dr. Shiv Jindal and wife Sarita donate $1 million to the Campaign to Create Tomorrow .

Dr. Shiv Jindal and his wife, Sarita, share a philosophical outlook when it comes to their philanthropy: If there’s something good and important happening for the benefit of the community, why not be part of it?

This straightforward perspective inspired them to support the creation of the New Campus Development on Carling Avenue through our historic Campaign to Create Tomorrow. With this project, they saw an opportunity to help their community while offering a sentimental nod to the hospital campus where Dr. Jindal spent an impressive 45-year career as a nephrologist after moving to Canada in 1967.

"If an opportunity comes your way to do something good, do it now. You may not have another chance"

Dr. Shiv and Sarita Jindal
Dr. Shiv Jindal and wife Sarita donate $1 million to the Campaign to Create Tomorrow.

Dr. Jindal helped establish the Department of Nephrology at the Civic Hospital when the field was in its infancy. Professionally, he is a passionate advocate for disease prevention, and in 2007, the Jindals donated $1 million to fund a chair at the hospital’s Kidney Research Centre for research to help prevent chronic kidney disease. Their most recent donation of $1 million underscores their profound desire to help make their city, and beyond, a healthier place. The Jindals view this gift as an investment in a campaign that has the power to improve the lives of patients and help redefine our approach to preventative healthcare, particularly at the New Campus Development.

The $500-million Campaign to Create Tomorrow ― the largest fundraising campaign in Ottawa’s history ― sets in motion a vision to transform how the world delivers healthcare by building the most technologically advanced hospital in Canada and taking groundbreaking research and innovation to unprecedented heights.

The Jindals have a long legacy of generosity and are highly respected among our local Indo-Canadian and medical communities. But their desire to improve the lives of others has never stopped at the Ottawa city limits. Most winters from 1995-2015, the Jindals would spend four to six weeks in India, working with more than 60 villages on disease prevention, education, and job creation. It would seem altruism is in their very DNA.

Thank you, Shiv and Sarita, for your inspirational generosity and steadfast commitment to making our city, and our world, a better place.

About the Campaign to Create Tomorrow

The Campaign to Create Tomorrow is the largest fundraising campaign in our region’s history. It will help fulfil the most ambitious vision ever for the future of The Ottawa Hospital, focused on four critical pillars.  

INNOVATION & TECHNOLOGY

See how we’ll become the most technologically advanced hospital in the country, using the latest tools to provide the right care in the right space with the right provider.
Learn More

WORLD LEADING RESEARCH

Through our unique collaborative model of clinicians and researchers working side-by-side, we will bring groundbreaking discoveries to patients in Ottawa — and around the world.
Learn More

STRENGTHENING CRITICAL SERVICES

From trauma care to cancer advancements to neuroscience, we will strengthen our critical services for patients across the region.
Learn More